Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in DCIS Breast Cancer
NCT00555152Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2009
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in ductal carcinoma in situ (DCIS), sponsored by National Cancer Institute. Started Aug 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT00555152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555152.